Genetic testing, innovative medicine ... popular concepts embrace the digitalization of medicine

On July 14, Jianzhi Bureau and Jingdong Health cooperated live broadcast "the second half of the second half of the pharmaceutical digital transformation (the second phase)", the theme "omni -channel, new cycle: the way to digitalizes the bureaucracy of smart marketing". This live broadcast mainly explores how the digitalization of medicines provides support for more professional fields such as innovative drugs and genetic testing.

Live broadcast invited Liu Yan, chief business officer of Beijing Pan -Shengzi Gene Technology Co., Ltd., and Wang Junxing, the head of Retail, China Retail, Emerging Market and Commerce of Nuohua Innovation Pharmaceuticals, and Fan Jing, the head of Digital Marketing Department of JD.com Health Pharmaceuticals. The application scenarios are pushed deeper.

The two guests from the industry shared the current improvement of the digitalization of medicine in the company.

Pan -born children are mainly engaged in genetic testing and early sieve of tumor.

Liu Yan

"The most direct thing is to cooperate with JD.com to promote the improvement of early screening of diseases. I hope that the public can form a consciousness of early screening of cancer."

Science is the most direct function of digitalization. Liu Yan admits that for ordinary people, genetic testing is very mysterious. Through digital channels, it can make popular science knowledge easy to understand. Understand what the genetic testing is, and where you can get early screening products. This provides convenience for the public.

In addition, online services can make patients more clear how the product uses and how to intelligently interpret the test results. The digital intervention has greatly expanded the breadth and depth of the morning screening, allowing patients to understand early screening, accept early screening, and actively apply early screening.

Wang Junxing from Novartis has a deeper understanding of digitalization. He said: "Today's marketing digitalization can be said to be online channels, out -of -hospital channels, so that digitalization is accelerating in the omnichannel marketing of drugs."

Novartis has both medicines and innovative medicines in China. Wang Junxing believes that patients who use general medicines can obtain the convenience of purchasing drugs through the Internet; for innovative drugs, the Internet has improved.

Wang Junxing

"For example, small diseases such as multiple muscle sclerosis, we have about 600 patients in the first year who are anxious to get the medicine. If according to the traditional path, it may take two or three months or longer. With JD.com's health, this is like this. Partners, we can guarantee that patients get medicine on the first week of listing. "

In addition, in the use of medicines, patients will also have various consulting needs. Digitalization can meet the needs of patients as soon as possible. Moreover, Novartis can understand these information to understand which needs of patients can occur online and which should be offline, which helps enterprises to further adjust the structure and service structure.

What can digitization do? Several guests of the conference also carried out imagination.

Liu Yan

"JD Health has a large traffic in this part of pharmaceutical e -commerce, which is a trusted platform. In terms of improving public science cognition, these traffic are very helpful. We can use this digital platform to achieve cost reduction reduction. Increase efficiency, provide products and services with high quality and low -cost products and services to users.

Make full use of the convenience of the Internet era, open up information flow, use new technologies, genetic testing, etc. The seemingly tall fields can also make ordinary people familiar with and applied. one.

Wang Junxing

In the past, many marketing work has been very low, "but digitalization is obviously different."

Patients can be closer to products and enterprises, and companies can better understand the needs of patients. Based on this, we can improve the service capabilities of patients, such as allowing patients to quickly get medicine, and to increase medicinal services around long -term medication. These are things that can be done in the future.

Writing | Jia Ting

Operation ｜ Twenty -thirty

- END -